0
Inquiry Basket
Quote

Brolucizumab

Cat# : THA-0118

Product Datasheets COA :
Cat#:  THA-0118
Product Name:  Brolucizumab
Description:  Brolucizumab is an anti VEGF-A monoclonal antibody indicated to treat neovascular age related macular degeneration.
Sequences:  Not Available
Molecular Weight:  26000.0 Da (approximate)
Introduction:  Brolucizumab, also known as RTH258 or ESBA1008, is a monoclonal antibody indicated to treat neovascular age related macular degeneration. Brolucizumab was granted FDA approval in October 2019.
Purity:  >99% by SDS-Page and HPLC analysis
Formula:  Not Available
Appearance:  Solid
For research use only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.

Online Inquiry

  • Size: 100ug 500ug 1mg 5mg 10mg 100mg 500mg 1g
  • Conjugation: None R-PE APC Biotin FITC Alexa Flour Others
CONTACT US

For more information on how our products could help advance your project, please contact us.

Contact Us

ENTER YOUR EMAIL HERE TO SUBSCRIBE.

Copyright © 2024 Creative BioMart. All Rights Reserved.